Who is sponsoring NCT05255640?

NCT05255640 is sponsored by Centre Hospitalier Universitaire de Nice.

What drugs are being tested in NCT05255640?

Interventions in NCT05255640: operation of ischemia of the lower limbs.

What condition does NCT05255640 study?

NCT05255640 studies Acute Ischemia of Lower Limb.

Is NCT05255640 still recruiting?

NCT05255640 is currently completed. Last updated 27 June 2024.

Last reviewed 2024-06-27 · How we verify

NCT05255640: DEVENIR-IAM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OUTCOME OF PATIENTS ADMITTED WITH ACUTE LOWER EXTREMITY ISCHEMIA

Completed Last updated 27 June 2024

What this trial tests

trial testing operation of ischemia of the lower limbs in Acute Ischemia of Lower Limb in 176 participants. Completed in 9 November 2023.

Timeline

4 March 2022

Primary endpoint
9 November 2023

9 November 2023

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Status	Completed
Study type	OBSERVATIONAL
Enrollment	176
Start date	4 March 2022
Primary completion	9 November 2023
Estimated completion	9 November 2023
Sites	14 locations across France

Drugs / interventions tested

operation of ischemia of the lower limbs

Conditions studied

Acute Ischemia of Lower Limb — all drugs for Acute Ischemia of Lower Limb →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

18 and older, any sex, with Acute Ischemia of Lower Limb. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute ischemia of the lower limb (AMI) is a life-threatening emergency that threatens the functional prognosis of the limb. Depending on the clinical presentation and the anatomy of the patient, several therapeutic approaches can be considered: open surgery, endovascular surgery, hybrid surgery or amputation if revascularization is not feasible. The data in the current literature do not allow to clearly establish which therapeutic approach is the most adapted to the patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05255640 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
Last refreshed: 27 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05255640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing